183 related articles for article (PubMed ID: 32300648)
21. Expression of Genes Associated with Telomere Homeostasis in TP53 Mutant LoVo Cell Lines as a Model for Genomic Instability.
Samassekou O; Bastien N; Yan J; Mai S; Drouin R
Methods Mol Biol; 2018; 1769():253-262. PubMed ID: 29564829
[TBL] [Abstract][Full Text] [Related]
22. Impact of germline CTC1 alterations on telomere length in acquired bone marrow failure.
Shen W; Kerr CM; Przychozen B; Mahfouz RZ; LaFramboise T; Nagata Y; Hanna R; Radivoyevitch T; Nazha A; Sekeres MA; Maciejewski JP
Br J Haematol; 2019 Jun; 185(5):935-939. PubMed ID: 30891747
[TBL] [Abstract][Full Text] [Related]
23. Dyskeratosis congenita associated with leukoplakia of the tongue.
Noto Z; Tomihara K; Furukawa K; Noguchi M
Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
[TBL] [Abstract][Full Text] [Related]
24. Cooperative interactions of p53 mutation, telomere dysfunction, and chronic liver damage in hepatocellular carcinoma progression.
Farazi PA; Glickman J; Horner J; Depinho RA
Cancer Res; 2006 May; 66(9):4766-73. PubMed ID: 16651430
[TBL] [Abstract][Full Text] [Related]
25. The short and long telomere syndromes: paired paradigms for molecular medicine.
Stanley SE; Armanios M
Curr Opin Genet Dev; 2015 Aug; 33():1-9. PubMed ID: 26232116
[TBL] [Abstract][Full Text] [Related]
26. DNA strand break-sensing molecule poly(ADP-Ribose) polymerase cooperates with p53 in telomere function, chromosome stability, and tumor suppression.
Tong WM; Hande MP; Lansdorp PM; Wang ZQ
Mol Cell Biol; 2001 Jun; 21(12):4046-54. PubMed ID: 11359911
[TBL] [Abstract][Full Text] [Related]
27. Dyskeratosis congenita: telomerase, telomeres and anticipation.
Marrone A; Walne A; Dokal I
Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
[TBL] [Abstract][Full Text] [Related]
28. A role for Brca1 in chromosome end maintenance.
McPherson JP; Hande MP; Poonepalli A; Lemmers B; Zablocki E; Migon E; Shehabeldin A; Porras A; Karaskova J; Vukovic B; Squire J; Hakem R
Hum Mol Genet; 2006 Mar; 15(6):831-8. PubMed ID: 16446310
[TBL] [Abstract][Full Text] [Related]
29. The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres.
Frank AK; Tran DC; Qu RW; Stohr BA; Segal DJ; Xu L
PLoS Genet; 2015 Jul; 11(7):e1005410. PubMed ID: 26230315
[TBL] [Abstract][Full Text] [Related]
30. Telomere dysfunction and hematologic disorders.
Paiva RM; Calado RT
Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
[TBL] [Abstract][Full Text] [Related]
31. Chromosome aberrations and telomere length modulation in bone marrow and spleen cells of melphalan-treated p53+/- mice.
Sgura A; De Amicis A; Stronati L; Cinelli S; Pacchierotti F; Tanzarella C
Environ Mol Mutagen; 2008 Jul; 49(6):467-75. PubMed ID: 18481314
[TBL] [Abstract][Full Text] [Related]
32. Short telomeres, even in the presence of telomerase, limit tissue renewal capacity.
Hao LY; Armanios M; Strong MA; Karim B; Feldser DM; Huso D; Greider CW
Cell; 2005 Dec; 123(6):1121-31. PubMed ID: 16360040
[TBL] [Abstract][Full Text] [Related]
33. Dyskeratosis congenita: a disorder of defective telomere maintenance?
Walne AJ; Marrone A; Dokal I
Int J Hematol; 2005 Oct; 82(3):184-9. PubMed ID: 16207588
[TBL] [Abstract][Full Text] [Related]
34. The wide-ranging clinical implications of the short telomere syndromes.
Barbaro PM; Ziegler DS; Reddel RR
Intern Med J; 2016 Apr; 46(4):393-403. PubMed ID: 26247919
[TBL] [Abstract][Full Text] [Related]
35. Dyskeratosis congenita: the diverse clinical presentation of mutations in the telomerase complex.
Vulliamy TJ; Dokal I
Biochimie; 2008 Jan; 90(1):122-30. PubMed ID: 17825470
[TBL] [Abstract][Full Text] [Related]
36. Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival.
Fang M; Simeonova I; Bardot B; Lejour V; Jaber S; Bouarich-Bourimi R; Morin A; Toledo F
Oncogene; 2014 Mar; 33(10):1336-9. PubMed ID: 23474762
[TBL] [Abstract][Full Text] [Related]
37. p53 pathway is involved in cell competition during mouse embryogenesis.
Zhang G; Xie Y; Zhou Y; Xiang C; Chen L; Zhang C; Hou X; Chen J; Zong H; Liu G
Proc Natl Acad Sci U S A; 2017 Jan; 114(3):498-503. PubMed ID: 28049824
[TBL] [Abstract][Full Text] [Related]
38. The germline p53 activation syndrome: A new patient further refines the clinical phenotype.
Kumar RD; Tosur M; Lalani SR; Mahoney DH; Bertuch AA
Am J Med Genet A; 2022 Jul; 188(7):2204-2208. PubMed ID: 35362179
[TBL] [Abstract][Full Text] [Related]
39. A novel DKC1 gene mutation c.1177 A>T (p.I393F) in a case of dyskeratosis congenita with severe telomere shortening.
Mohanty P; Jadhav P; Shanmukhaiah C; Kumar S; Vundinti BR
Int J Dermatol; 2019 Dec; 58(12):1468-1471. PubMed ID: 30868555
[No Abstract] [Full Text] [Related]
40. Telomere length and cancer risk: finding Goldilocks.
Savage SA
Biogerontology; 2024 Apr; 25(2):265-278. PubMed ID: 38109000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
